Aurobindo gets approval for cefazolin for injection USP

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo gets approval for cefazolin for injection USP

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) for Cefazolin for Injection USP 500mg/vial and 1gram/vial

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo Pharma gets approval for Alendronate Sodium Tabs Aurobindo Pharma cons revenues up 27.6% to Rs 684.7cr Aurobindo Pharma Q1 net profit at Rs 16.4 cr ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) for Cefazolin for Injection USP 500mg/vial and 1gram/vial. This is a Sterile Cephalosporin product under the anti-infective segment and generic equivalent to Abraxis Pharmaceutical Products' Reference Listed Drug Cefazolin for injections USP 500mg/vial and 1gram/vial.

This is the third product approval of the Sterile Injectable Formulation line of Unit VI-B, situated in Hyderabad, India by USFDA.

Aurobindo now has 74 ANDAs approved by the USFDA. 

Sourced From: Aurobindo Pharma Limited